In this framework, the novel dual GIP and GLP-1 receptor agonist tirzepatide seems to be not just a new antidiabetic medication
Lin CP, Traets JJH, Vredevoogd DW, Visser NL, Peeper DS
Older adults and people taking metformin or acid-suppressing drugs who have confirmed low levels or absorption issues (NIH ODS)
Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
Will we develop oral or longer-acting versions
Curr Urol Rep